The competition's heating up over a $35 billion market to treat NASH, a 'silent disease' millions are living with. But some of the early results don't look promising.

7:17am PST - February 12th, 2019    fat tuesday - Business Insider

NASH, short for nonalcoholic steatohepatitis, is a type of liver disease in which liver fat builds up in people. It affects an estimated 16 million Americans, but many don't know it until it leads to more serious problems like liver failure and cirrhosis. Dru…